TapImmune Inc (TPIV.OQ)
TPIV.OQ on NASDAQ Stock Exchange Capital Market
8.22USD
14 Aug 2018
8.22USD
14 Aug 2018
Change (% chg)
$0.51 (+6.61%)
$0.51 (+6.61%)
Prev Close
$7.71
$7.71
Open
$7.70
$7.70
Day's High
$8.25
$8.25
Day's Low
$7.70
$7.70
Volume
11,077
11,077
Avg. Vol
90,844
90,844
52-wk High
$13.54
$13.54
52-wk Low
$2.60
$2.60
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Peter Hoang |
44 | 2017 | President, Chief Executive Officer, Director |
Michael Loiacono |
48 | 2016 | Chief Financial Officer, Chief Accounting Officer, Treasurer, Corporate Secretary |
Mark Reddish |
60 | 2014 | Vice President Development |
Richard Kenney |
57 | 2017 | Acting Chief Medical Officer |
David Laskow-Pooley |
58 | 2015 | Director |